Diagnosis and management of nephrotic syndrome in adults

American Family Physician

Volumn 93, Issue 6, 2016, Pages 479-485

  Kodner, Charles ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CHLORAMBUCIL; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CORTICOSTEROID; CORTICOTROPIN; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ECULIZUMAB; FUROSEMIDE; MYCOPHENOLATE MOFETIL; RITUXIMAB; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; ANTICOAGULATION; ARTICLE; CELLULITIS; ECHOGRAPHY; FOCAL GLOMERULOSCLEROSIS; HUMAN; HYPERLIPIDEMIA; HYPOALBUMINEMIA; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FUNCTION TEST; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PERIPHERAL EDEMA; PROTEINURIA; SODIUM RESTRICTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; URINALYSIS; VEIN THROMBOSIS; BIOPSY; DISEASE MANAGEMENT;

ADRENAL CORTEX HORMONES; ADULT; BIOPSY; DISEASE MANAGEMENT; HUMANS; IMMUNOSUPPRESSIVE AGENTS; NEPHROTIC SYNDROME;

EID: 84960977123     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hull RP, Goldsmith DJ. Nephrotic syndrome in adults. BMJ. 2008;336(7654):1185-1189.
2. Williams WW Jr, Ecker JL, Thadhani RI, Rahemtullah A. Case records of the Massachusetts General Hospital. Case 38-2005. A 29-year-old pregnant woman with the nephrotic syndrome and hypertension. N Engl J Med. 2005;353(24):2590-2600.
3. Floege J. Introduction to glomerular disease: clinical presentations. In: Johnson RJ, Feehally J, Floege J, eds. Comprehensive Clinical Nephrology. 5th ed. Philadelphia, Pa.: Elsevier Saunders; 2015.
4. Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82(6):635-642.
5. Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012; 7(3):513-520.
6. Kayali F, Najjar R, Aswad F, Matta F, Stein PD. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am J Med. 2008;121(3):226-230.
7. Pincus KJ, Hynicka LM. Prophylaxis of thromboembolic events in patients with nephrotic syndrome. Ann Pharmacother. 2013;47(5):725-734.
8. Wu HM, Tang JL, Cao L, Sha ZH, Li Y. Interventions for preventing infection in nephrotic syndrome. Cochrane Database Syst Rev. 2012;(4):CD003964.
9. Koomans HA. Pathophysiology of acute renal failure in idiopatic nephrotic syndrome. Nephrol Dial Transplant. 2001;16(2):221-224.
10. Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L. Lipid-lowering agents for nephrotic syndrome. Cochrane Database Syst Rev. 2013;(12): CD005425.
11. Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patient. Kidney Int. 2012;82(8):840-856.
12. Furosemide dosage. Drugs.com. http://www.drugs.com/dosage/furosemide.html. Accessed January 13, 2016.
13. Glassock RJ. Prophylactic anticoagulation in nephrotic syndrome. J Am Soc Nephrol. 2007;18(8):2221-2225.
14. Mahmoodi BK, Mulder AB, Waanders F, et al. The impact of antiproteinuric therapy on the prothrombotic state in patients with overt proteinuria. J Thromb Haemost. 2011;9(12):2416-2423.
15. Chen Y, Schieppati A, Chen X, et al. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome. Cochrane Database Syst Rev. 2014;(10):CD004293.
16. McQuarrie EP, Stirling CM, Geddes CC. Idiopathic membranous nephropathy and nephrotic syndrome. Nephrol Dial Transplant. 2012;27(1):235-242.
17. Korbet SM. Treatment of primary FSGS in adults. J Am Soc Nephrol. 2012;23(11):1769-1776.
18. Kodner C. Nephrotic syndrome in adults: diagnosis and management. Am Fam Physician. 2009; 80(10): 1129-1134.